Otomagnetics
bg1-1.png
What People are Saying about Otomagnetics
This novel technology has the potential to save health system costs in multiple disease areas by offering treatments that could reduce the number of interventions, including surgeries. It’s also a great example of translating science from a public university into practical applications for the benefit of patients, caregivers and society overall. I'm looking forward to working with the team at Otomagnetics as they work toward bringing this exciting technology to the market.
- Eric M. Kraus, Otomagnetics Advisor and ENT Otolaryngologist, The Ear Center of Greensboro, PA of Otonomy
Otomagnetics technology enhances, non-invasive steroid delivery to the cochlea to help preserve residual hearing during cochlear implant procedures (e.g. potential to further extend indications for cochlear implants). The technology could provide us with so many new options for both current treatment and treatments that we have not even contemplated yet that uses for the technology may only be limited by our imaginations. Otomagnetics technology offers a completely new paradigm for the entire field of medicine. Most medical advances tend to be incremental iterations of existing technologies. Otomagnetic’s technology will be a quantum change.
- Tony Yost, Otomagnetics advisor and former CCO of Otonomy
quote-left2.png
quote-right2.png
quote-left.png
quote-right.png
bg-1.1
What People are Saying about Otomagnetics
Ocular injections can be a stressful procedure for many patients suffering from sight threatening stressful conditions requiring on-going disease treatment. Otomagnetics is working hard to revolutionize how we deliver numerous treatments, including sight-saving drugs without the stress or potential complications associated with ocular injections. Using a magnetic device and a magnetic nanoparticle drug formulation Otomagnetics hopes to simplify ocular drug delivery in the near future by noninvasively “pushing” the drug particles to their target tissue. Myriad patients with conditions such as glaucoma and retinitis pigmentosa will one day benefit from the ground breaking work that Otomagnetics is doing today.
- Dr. Alexander Kabiri O.D, Otomagnetics Advisor and President, American Eye Association
- Dr. Kaukab Rajput, FRCS,FRCP Consultant Physician, Great Ormond St Hospital for Sick Children NHS trust, London.
Magnetic delivery of drugs could dramatically improve the care of children with ear conditions. It could avoid the need for surgery in kids with chronic/recurrent middle ear infections, and it could potentially preserve hearing in kids receiving ototoxic drugs or radiotherapy.
quote-left2.png
quote-right2.png
quote-left2.png
quote-right2.png

WHY OTOMAGNETICS

About Us

laptop-tiny

Otomagnetics is developing a non-invasive method to deliver drugs and other therapeutic payloads to inner and middle ear compartments, to the eye, and into the skin. The inner ear is behind the blood-labyrinth barrier – vessels that supply blood to the inner ear have walls that are impermeable to most drug molecules, and thus it is a challenge to deliver therapy to treat inner ear diseases.

Otomagnetics’ proprietary magnetic injection system has demonstrated drug delivery to the inner ear in animal models. Otomagnetics’ technology has further shown drug delivery to the middle ear in animal models without the need to puncture the eardrum. Magnetic delivery to the middle ear may provide a non-invasive treatment use. In the future, the Otomagnetic’s technology may be investigated for delivering therapy into the eye, without needles. For more information, visit our Technology page.

Our Solution

 


 

NEWS Room

The Statesman
SNS Web | New Delhi | September 23, 2020 1:25 pm

Natural born leader Abhita Batra merges her scientific expertise with superior management skills
In the biotechnology space, only a handful of companies manage to cut through the noise and successfully achieve their full potential in the midst of increasingly complex and volatile conditions.
View article

Forbes India
PUBLISHED: Sep 14, 2020 11:00:48 AM IST
Biotech CEO Abhita Batra champions groundbreaking magnetic drug delivery technology
Abhita Batra, a young and visionary scientist - turned Chief Executive Officer - is on a quest to successfully re-imagine patient experience.
View article

American Daily Post
Abhita Batra
 AUGUST 6, 2020  BRYCE ROSS
This startup is working to improve children’s lives through technology
View article

More News



Top of page